Cargando…

Profile: immatics biotechnologies GmbH

Detalles Bibliográficos
Autor principal: Higham, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667922/
http://dx.doi.org/10.4161/hv.23611
_version_ 1782271557148606464
author Higham, Paul
author_facet Higham, Paul
author_sort Higham, Paul
collection PubMed
description
format Online
Article
Text
id pubmed-3667922
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-36679222013-06-27 Profile: immatics biotechnologies GmbH Higham, Paul Hum Vaccin Immunother News, Policy and Profiles Landes Bioscience 2013-01-01 2013-01-01 /pmc/articles/PMC3667922/ http://dx.doi.org/10.4161/hv.23611 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle News, Policy and Profiles
Higham, Paul
Profile: immatics biotechnologies GmbH
title Profile: immatics biotechnologies GmbH
title_full Profile: immatics biotechnologies GmbH
title_fullStr Profile: immatics biotechnologies GmbH
title_full_unstemmed Profile: immatics biotechnologies GmbH
title_short Profile: immatics biotechnologies GmbH
title_sort profile: immatics biotechnologies gmbh
topic News, Policy and Profiles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667922/
http://dx.doi.org/10.4161/hv.23611
work_keys_str_mv AT highampaul profileimmaticsbiotechnologiesgmbh